// App-Quantinova.ai

CTP7 2015 ASA : The FRONTIER trial: Field Randomization Of NA-1 Treatment By Early Responders

Researchers

Presenter

  • Michael D Hill

Principal Investigators

  • Gordon Neville

  • Jim Christenson

  • Devin Harris

  • Paul R Leslie

  • William Dick

  • Richard Swartz

  • Daniel Selchen

  • Leanne Casaubon

  • Manu Mehdiratta

  • Paul Raftis

  • Yael Perez

  • Oscar Benavente

  • Garrie Wright

  • Gary Mcauley

  • Richard Verbeek

  • Sheldon Cheskes

  • Peter Dundas

  • Priya Kakar

Medical Centers

  • Univ of Calgary, Calgary, Canada

  • Sunnybrook Ctr for Prehospital Med, Toronto, ON, Canada

  • Toronto Western Hosp Regional Stroke Ctr, Toronto, ON, Canada

  • British Columbia Emergency Medical Services, Vancouver, BC, Canada

  • Vancouver General Hosp Regional Stroke Ctr, Vancouver, BC, Canada

  • Sunnybrook Health Sciences Ctr Regional Stroke Ctr, Toronto, ON, Canada

  • The University of British Columbia, Vancouver, BC, Canada

  • Peel Regional Paramedic Services, Mississauga, ON, Canada

  • U Toronto, Toronto, ON, Canada

  • St. Michael's Hosp Regional Stroke Ctr, Toronto, ON, Canada

  • Trillium Health Partners Regional Stroke Ctr, Mississauga, ON, Canada

  • BCCA, Vancouver, BC, Canada

  • St. Michael's Hosp, Toronto, ON, Canada

  • Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Epilepsy

  • Stroke

  • Trauma

Biomarkers

  • N/A

Drug/Treatment

  • Tat-NR2B9c

Outcome

  • N/A

Study Design

  • randomized

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved